AKAN
Akanda Corp.NASDAQHealthcare$0.69-0.99%ClosedMarket Cap: $100,217
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.09
P/S
0.29
EV/EBITDA
0.82
DCF Value
$-9.23
FCF Yield
-2408.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.3%
Operating Margin
-978.8%
Net Margin
-619.5%
ROE
-58.8%
ROA
-35.9%
ROIC
-95.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | $0.00 | $-815.0K | $-2.06 |
| Q4 2024 | $359.7K | $-1.4M | $-1.09 |
| FY 2024 | $836.7K | $-4.1M | $-3.93 |
| Q2 2024 | $477.0K | $-2.7M | $-2.84 |
Trading Activity
Insider Trades
View AllHRT FINANCIAL LP10 percent owner
BuyTue Jan 20
HRT FINANCIAL LP10 percent owner
SellTue Jan 20
HRT FINANCIAL LP10 percent owner
SellTue Jan 20
Company Info
Sector
Healthcare
Industry
—
Country
GB
Exchange
NASDAQ
Beta
1.73
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.